Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of sodium-glucose cotransporter 2 suppresses renal stone formation
Go Anan, Takuo Hirose, Daisuke Kikuchi, et al.
Pharmacological Research (2022) Vol. 186, pp. 106524-106524
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
Julie M. Paik, Helen Tesfaye, Gary C. Curhan, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 3, pp. 265-265
Closed Access | Times Cited: 21
Effects of SGLT2 inhibition via empagliflozin on cognitive and physical impairment in frail diabetic elders with chronic kidney disease
Pasquale Mone, Germano Guerra, Angela Lombardi, et al.
Pharmacological Research (2024) Vol. 200, pp. 107055-107055
Open Access | Times Cited: 12
Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Urolithiasis
Go Anan, Daisuke Kikuchi, Takuo Hirose, et al.
Kidney International Reports (2023) Vol. 8, Iss. 4, pp. 925-928
Open Access | Times Cited: 15
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial
Manuel Anderegg, Simeon Schietzel, Matteo Bargagli, et al.
Nature Medicine (2025)
Open Access
Secondary hyperoxaluria: Cause and consequence of chronic kidney disease
Loreto Mariscal de Gante, Laura Salanova, Mariel Valdivia Mazeyra, et al.
Nefrología (English Edition) (2025)
Open Access
Inhibition of NLRP3 alleviates calcium oxalate crystal-induced renal fibrosis and crystal adhesion
Yuexian Xu, Guoxiang Li, Wanqing Liu, et al.
Urolithiasis (2025) Vol. 53, Iss. 1
Closed Access
Use of Sodium‐Glucose Transport Protein 2 Inhibitors and the Incidence of Urolithiasis: A Multi‐Database and Cross‐Country Study in Patients With Type 2 Diabetes Mellitus
Mu‐Chi Chung, Chia‐Yen Lin, Chao‐Hsiang Chang, et al.
Clinical Pharmacology & Therapeutics (2025)
Open Access
Construction of arginine vasopressin receptor 2-deficient rats by the rGONAD method
Ayaka Kamada, Takuo Hirose, Shigemitsu Sato, et al.
Clinical and Experimental Nephrology (2025)
Closed Access
Tubular damage and SGLT2 expression in a patient with Beni-koji tablet-associated acute kidney injury and Fanconi syndrome
Ayaka Kamada, Takuo Hirose, H Hashimoto, et al.
CEN Case Reports (2025)
Closed Access
Sodium glucose co-transporter 2 inhibitor prevents nephrolithiasis in non-diabetes by restoring impaired autophagic flux
Chan-Jung Liu, Kuo-Ting Ho, Ho‐Shiang Huang, et al.
EBioMedicine (2025) Vol. 114, pp. 105668-105668
Closed Access
Sodium-glucose cotranspor ter 2 (SGLT2) inhibitors in nephrolithiasis: should we “gliflozin” patients with kidney stone disease?
Maurício Carvalho, Ita Pfeferman Heilberg
Brazilian Journal of Nephrology (2024)
Open Access | Times Cited: 3
Lithocarpus polystachyus Rehd. ameliorates cerebral ischemia/reperfusion injury through inhibiting PI3K/AKT/NF-κB pathway and regulating NLRP3-mediated pyroptosis
Daifang Liu, Wendan Wu, Tingting Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Untargeted and targeted metabolomics reveal bile acid profile changes in rats with ethylene glycol-induced calcium oxalate nephrolithiasis
Zijian Zhou, Dexiang Feng, Donghui Shi, et al.
Chemico-Biological Interactions (2023) Vol. 381, pp. 110570-110570
Closed Access | Times Cited: 6
Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity
Pedro Baltazar, Antônio Ferreira de Melo, Nuno Moreira Fonseca, et al.
Genes (2023) Vol. 14, Iss. 9, pp. 1719-1719
Open Access | Times Cited: 6
Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion
Akari Endo, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 47, Iss. 1, pp. 33-45
Open Access | Times Cited: 6
Pericyte detachment and renal congestion involve interstitial injury and fibrosis in Dahl salt-sensitive rats and humans with heart failure
Hiroki Ito, Takuo Hirose, Shigemitsu Sato, et al.
Hypertension Research (2023) Vol. 46, Iss. 12, pp. 2705-2717
Open Access | Times Cited: 5
SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis
Mehmet Kanbay, Crischentian Brinza, Sidar Çöpür, et al.
Nephrology Dialysis Transplantation (2024)
Closed Access | Times Cited: 1
Sodium-glucose cotransporter-2 inhibitors increase urinary tract infections?—a cross sectional analysis of a nationwide Japanese claims database
Go Anan, Daisuke Kikuchi, Kenji Omae, et al.
Endocrine Journal (2023) Vol. 70, Iss. 11, pp. 1103-1107
Open Access | Times Cited: 3
Investigating the association between the administration of SGLT-2 inhibitors and the risk of urinary tract infection; a systematic review and meta-analysis
Ramin Haghighi, Nasim Zaman samghabadi, Roya Raeisi Jaski, et al.
Journal of Renal Injury Prevention (2024)
Open Access
Prevention, diagnosis, and treatment of urolithiasis in geriatric patients - differences, similarities and caveats in comparison to the general population
Tarek A. Schrag, Danielle Diarra, Julian Veser
Current Opinion in Urology (2024) Vol. 34, Iss. 3, pp. 154-165
Closed Access
SGLT-2 Inhibitors and Their Correlation With Kidney Stones. A Systematic Review
Bander J. Alshehri, Hani Sadaka Shalabi
Journal of Health and Rehabilitation Research (2024) Vol. 4, Iss. 2, pp. 282-290
Open Access
Intestine-Settled Electrospun Short-Fibers Modulate Epithelial Transport Proteins to Reduce Purine and Glucose Uptake
Yunkai Tang, Juan Wang, Zhengwei Cai, et al.
Advanced Fiber Materials (2024)
Closed Access
Isovaleramide attenuates ethylene glycol poisoning‐induced acute kidney injury and reduces mortality by inhibiting alcohol dehydrogenase activity in rats
Kai Yang, Xiaoxia Zhang, Jianzhong Yang, et al.
Basic & Clinical Pharmacology & Toxicology (2024)
Open Access
SGLT2 Inhibitors and Their Effect on Urolithiasis: Current Evidence and Future Directions
Živka Dika, Marijana Živko, Marina Kljajić, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 19, pp. 6017-6017
Open Access
Preliminary Study: Expulsive Effect of Empagliflozin on Small Lower Ureteric Stones in Type II Diabetic Patients
Alsayed Saad Abdelaziz, Mohab AS. Abdalaziz, Maher Hassan Ebraheem, et al.
Al-Azhar Assiut Medical Journal (2024) Vol. 22, Iss. 1, pp. 31-37
Open Access
Page 1 - Next Page

Scroll to top